Madrigal Pharmaceuticals
MDGL
MDGL
97 hedge funds and large institutions have $148M invested in Madrigal Pharmaceuticals in 2015 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 38 increasing their positions, 24 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
31% less call options, than puts
Call options by funds: $695K | Put options by funds: $1.01M
Holders
97
Holding in Top 10
1
Calls
$695K
Puts
$1.01M
Top Buyers
| 1 | +$1.91M | |
| 2 | +$892K | |
| 3 | +$844K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$521K |
| 5 |
D.E. Shaw & Co
New York
|
+$517K |
Top Sellers
| 1 | -$6.29M | |
| 2 | -$6.29M | |
| 3 | -$1.44M | |
| 4 |
Renaissance Technologies
New York
|
-$1.27M |
| 5 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$970K |